Хайлтын үр дүнгүүд - Hashimoto, Akihiro
- 8-н 1 - 8 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
Localization of the Optical Phonon Modes in Boron Nitride Nanotubes: Mixing Effect of (10)B Isotopes and Vacancies -н Islam, Md. Sherajul, Howlader, Ashraful Hossain, Zheng, Rongkun, Stampfl, Catherine, Park, Jeongwon, Hashimoto, Akihiro
Хэвлэсэн 2022текст -
4
Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways -н Muraoka, Hiromi, Yoshimura, Chihoko, Kawabata, Rumi, Tsuji, Shingo, Hashimoto, Akihiro, Ochiiwa, Hiroaki, Nakagawa, Fumio, Fujioka, Yayoi, Matsuo, Kenichi, Ohkubo, Shuichi
Хэвлэсэн 2019текст -
5
Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans -н Zezula, Josef, Singer, Lisa, Przybyl, Anna K., Hashimoto, Akihiro, Dersch, Christina M., Rothman, Richard B., Deschamps, Jeffrey, Lee, Yong Sok, Jacobson, Arthur E., Rice, Kenner C.
Хэвлэсэн 2008текст -
6
Probes for Narcotic Receptor Mediated Phenomena. 37.1 Synthesis and Opioid Binding Affinity of the Final Pair of Oxide-Bridged Phenylmorphans, the ortho- and para-b Isomers and The... -н Kurimura, Muneaki, Liu, Hehua, Sulima, Agnieszka, Hashimoto, Akihiro, Przybyl, Anna K., Ohshima, Etsuo, Kodato, Shinichi, Deschamps, Jeffrey R., Dersch, Christina M., Rothman, Richard B., Lee, Yong Sok, Jacobson, Arthur E., Rice, Kenner C.
Хэвлэсэн 2008текст -
7
High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells -н Fujita, Hidenori, Gomori, Akira, Fujioka, Yayoi, Kataoka, Yuki, Tanaka, Kenji, Hashimoto, Akihiro, Suzuki, Takamasa, Ito, Kenjiro, Haruma, Tomonori, Yamamoto-Yokoi, Hiromi, Harada, Naomoto, Sakuragi, Motomu, Oda, Nobuyuki, Matsuo, Kenichi, Inada, Masaki, Yonekura, Kazuhiko
Хэвлэсэн 2016текст -
8
TAS6417/CLN-081 is a pan-mutation-selective EGFR tyrosine kinase inhibitor with a broad spectrum of preclinical activity against clinically-relevant EGFR mutations -н Udagawa, Hibiki, Hasako, Shinichi, Ohashi, Akihiro, Fujioka, Rumi, Hakozaki, Yumi, Shibuya, Mikiko, Abe, Naomi, Komori, Toshiharu, Haruma, Tomonori, Terasaka, Miki, Fujita, Ryoto, Hashimoto, Akihiro, Funabashi, Kaoru, Yasuda, Hiroyuki, Miyadera, Kazutaka, Goto, Koichi, Costa, Daniel B., Kobayashi, Susumu S.
Хэвлэсэн 2019текст